Construction method and application of recombinant chimeric Newcastle disease virus for expressing chicken infectious bursal disease virus variant VP2 gene
A technology for Newcastle disease virus and bursal disease, which can be used in applications, antiviral agents, genetic engineering, etc., and can solve problems such as the limitation of clinical application of recombinant live vector vaccines
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0052] Embodiment 1 has the construction of the LaSota strain infectious clone of the F gene of gene VII type NDV epidemic strain HN gene and alkaline protease cleavage site amino acid mutation
[0053] 1.1 Construction of infectious clone plasmid of NDV LaSota vaccine strain
[0054] According to the sequence of the NDV LaSota strain published in GenBank (GenBank accession number AF077761), 7 cDNA fragments covering the entire genome were cloned into the transcription vector pOLTV5 by overlapping PCR to obtain the recombinant plasmid pLaSota. The recombinant plasmid pLaSota is as follows: figure 1 Shown; It should be noted that: the complete LaSota genome cDNA has T7 RNA polymerase promoter upstream, delta hepatitis virus (HDV) ribozyme sequence (ribozyme) and T7 transcription termination sequence downstream.
[0055] 1.2 Construction of recombinant vectors containing F and HN genes of type VII NDV epidemic strains
[0056] According to the genome sequence of the gene VII ty...
Embodiment 2
[0070] Embodiment 2 has the rescue of the recombinant LaSota strain of the F gene of gene VII type NDV epidemic strain HN gene and alkaline protease cleavage site amino acid mutation
[0071] 2.1 Construction of transcriptional helper plasmids expressing NDV LaSota vaccine strain nucleoprotein (NP), phosphoprotein (P) and large polymerase protein (L)
[0072] The cDNA sequence encoding the large polymerase protein (L) of the NDV LaSota vaccine strain was cloned into the downstream of the CMV promoter of the pCI-neo eukaryotic expression vector; The sequence was cloned into the downstream of the SV40 promoter of the pCI-neo eukaryotic expression vector after tandem, and the transcription plasmid pCI-NP-P-L, which simultaneously expresses NP, P and L proteins, was obtained. Specifically, the following schemes are adopted:
[0073] a. Preparation of NP-2A-P
[0074] Using the pLaSota plasmid as a template, using primers targeting NP:
[0075] NP-F: 5'-ATGTCTTCCGTATTTGATGAG-3';...
Embodiment 3
[0089] Example 3 Construction of recombinant chimeric Newcastle disease virus expressing chicken infectious bursal disease virus mutant strain VP2 gene
[0090] 3.1 Main reagents and materials
[0091] The plasmid pLaSota-7F-7HN of the chimeric NDV LaSota-7F-7HN full-length genome cDNA containing gene VII type NDV strain F and HN genes constructed by embodiment 1; the expression LaSota strain NP, P and L protein helper plasmid pCI-NP-P-L.
[0092] The pGEM-PM shuttle vector was constructed by the applicant. Specifically, the pGEM-PM shuttle vector was cloned into the P and M part genes of the NDV LaSota strain and the two Between the P and M sequences, additional NDV gene end (GE) and gene start (GS) sequences were introduced, and two Sap I restriction endonuclease sites were introduced downstream of GE and GS point to facilitate the insertion of foreign genes. The sequences cloned into the Apa I and Pml I restriction endonuclease sites in the pGEM commercial vector are sho...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com